IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sevion Therapeutics

CUSIP: 81834Q104 | 2 institutional holders

Quarters

Q1 2017Q4 2016Q3 2016Q2 2016Q1 2016
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2017

Perceptive Advisors LLC59,220
0.0% of portfolio›$9
StyleTurnoverLocationFiled
Perceptive Advisors LLC
59,220$90.0%CoreHighNew York, NY2017-05-15